- Home
- Reagents
- Overview
- Primary Antibodies
- Overview
- Anti-Allergen Antibodies
- Anti-Coronavirus Antibodies
- Anti-Virus Antibodies
- Antibodies to Epitope Tags
- DNA/RNA Research Antibodies
- Immunotherapy Research Antibodies
- Murine Bispecific Antibody Reagents
- Neuroscience Research Antibodies
- Recombinant Antibodies from Human Patients
- Recombinant Isotype Controls
- Research-Grade Biosimilars
- Tumor Marker Antigens
- VivopureX™ Antibodies for In Vivo Research
- Secondary Antibodies
- Recombinant Proteins
- Services
- Our Technology
- About Us
- Antibody Resource
- News & Events
- How to Order
Antibody Name [Clone]
Expected Species Reactivity
Applications
-
Anti-SARS-CoV S glycoprotein [F26G10]SARS CoronavirusNTRL, ELISA, IF
-
Anti-SARS-CoV S glycoprotein [F26G19]SARS CoronavirusNTRL, WB, ELISA, IF
-
Anti-Spike protein (RBD) [Sb#68]SARS Coronavirus 2 (SARS-Cov-2)grating-coupled interferometry, inhibition, therapeutics, ELISA
-
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-E7-C9]SARS Coronavirus 2 (SARS-Cov-2)ELISA
-
Anti-Spike protein (RBD) [Sb#16]SARS Coronavirus 2 (SARS-Cov-2)grating-coupled interferometry, inhibition, therapeutics, ELISA
-
Anti-COVID-19 & SARS-CoV S glycoprotein [CR3022]SARS-CoV-2 (COVID-19) & SARS Coronaviruscrystallography, NTRL, SPR, ELISA, IF
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3018 (03-018)]SARS-CoV, SARS-CoV2ELISA, IF
-
Anti-Covid-19 & SARS-CoV Nucleoprotein [CR3009 (03-009)]SARS-CoV, SARS-CoV2ELISA, IF
-
Anti-NP [JS08]SARS-CoV-2SPR, WB, ELISA
-
Anti-Covid-19 & SARS-CoV Nucleocapsid [1C7C7]SARS-CoV, SARS-CoV-2WB, ELISA, FC, IHC
-
Anti-NP [JS16]SARS-CoV-2SPR, WB, ELISA
-
Anti-Spike protein (RBD) [Sb#42]SARS Coronavirus 2 (SARS-Cov-2)grating-coupled interferometry, inhibition, therapeutics, ELISA
-
Anti-Spike protein (RBD) [Sb#45]SARS Coronavirus 2 (SARS-Cov-2)grating-coupled interferometry, inhibition, therapeutics, ELISA
-
Anti-SARS-CoV-2 Spike protein (RBD monomer) [2B-G10-A1]SARS Coronavirus 2 (SARS-Cov-2)ELISA
-
Anti-Spike protein [3B-D7-C2]SARS Coronavirus 2 (SARS-Cov-2)ELISA
-
Anti-Spike Protein [CV1]SARS Coronavirus 2neutralize, therapeutic, ELISA, FC
-
Anti-Spike protein [4A8]SARS Coronavirus 2 (SARS-Cov-2)functional assay, neutralizing, ELISA, FC
-
Anti-Spike protein [SR4]SARS Coronavirus 2 (SARS-Cov-2)biolayer interferometry, FACS, NTRL, therapeutic, ELISA
-
Anti-Spike Protein (RBD) [CV30]SARS Coronavirus 2neutralize, therapeutic, ELISA, FC
-
Anti-Spike protein [3B-G3-C6]SARS Coronavirus 2 (SARS-Cov-2)ELISA
-
Anti-S protein (RBD) [aRBD-2]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [aRBD-5]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-Spike protein (RBD) [Sb#15]SARS Coronavirus 2 (SARS-Cov-2)grating-coupled interferometry, inhibition, therapeutics, ELISA
-
Anti-S protein (RBD) [STE90-C11]SARS-CoV-2biolayer interferometry, crystallography, in vitro inhibition, in vitro neutralization, in vivo protection, therapeutic, ELISA
-
Anti-Spike protein [18F4]SARS Coronavirus 2 (SARS-Cov-2)functional assay, SPR, Block, ELISA
-
Anti-S protein (RBD) [aRBD-7]SARS-CoV-2Blocking, neutralizing, SPR, ELISA
-
Anti-S protein (RBD) [1E2]SARS-CoV-2neutralizing, SPR, ELISA
-
Anti-S protein [P17]SARS-CoV-2in vivo, neutralizing, SPR, ELISA, IF
-
Anti-S protein (RBD) [5F8]SARS-CoV-2in vitro neutralization, SPR
-
Anti-Spike protein [D70678-5521-S2]SARS Coronavirus 2 (SARS-Cov-2)functional assay, SPR, ELISA